| Tuesday, November 10th |
| 5:00-6:45pm |
Welcome Reception
| Hosted By: |
 |
|
|
| Wednesday, November 11th |
| 7:30-8:30 |
Networking Breakfast |
| 8:30-8:45 |
Opening Remarks |
| |
Conference Chairman:
Peter G Kleinhenz
Venture Partner - Fletcher Spaght Ventures
Managing Director
CID Capital, Inc. |
Host Committee Chairman:
Tom Still
President
Wisconsin Technology Council |
|
| |
| 8:45-9:00 |
Welcome to Madison
Governor Jim Doyle
Wisconsin |
| |
| 9:00-9:45 |
The Impact on Health Care Reform
This discussion will highlight the adoption of new technology, delivery of care to rural
areas, changes in insurance policies and incentives for preventative healthcare.
|
| |
Moderator:
George Emont
Managing Director
Triathlon Medical Ventures |
|
Panelists:
Paul Kusserow
Senior Vice President & Chief Strategy Officer
Humana Inc. |
Kelly Slone
Director of Federal Life Science Policy
National Venture Capital Association |
Mark Koch
Chief Administrative Officer
Mayo Health System Administration |
|
|
| |
| 9:45-10:30 |
Stimulating the Public Equity Market’s Appetite for Healthcare Companies |
| |
Industry experts representing the most successful venture backed exits will provide their own unique perspective on the IPO market.
- The glimmer of hope seen in recent filings and what that means to VCs and their portfolio companies
- What is necessary and what will happen to re-open the public markets
|
| |
| |
Moderator:
Charles O’Meara
Senior Managing Director - Private Equity
B.C. Ziegler & Company |
|
Panelists:
Rick Mattoon
Senior Economist & Economic Advisor
Federal Reserve Bank |
John Taylor
Research & Financial Affairs Executive
National Venture Capital Association |
Brian Scullion
Principal
William Blair & Company |
|
|
| |
| 10:30-11:00 |
Networking & Refreshment Break
| Hosted By: |
 |
|
| 11:00-12:30 |
Presenting Company Showcase |
| |
TRACK 1 Biotechnology & Pharmaceutical Showcase
| Time |
Company |
Presenter |
| 11:00-11:10 |
Cellular Dynamics International, Inc. |
Bob Palay
Chief Executive Officer |
| 11:10-11:20A.M |
Shiloh Laboratories |
Thomas Primiano
Founder |
| 11:20-11:30 |
Addiction Therapeutix, Inc. |
Frank Langley
President & CEO |
| 11:30-11:40 |
ImmunoGenetix Therapeutics, Inc. |
Jim Laufenberg
President & CEO |
| 11:40-11:50 |
FluGen Inc. |
Paul Radspinner
President & CEO |
| 11:50-12:00 |
Galera Therapeutics, LLC |
Dennis Riley, Ph.D.
CSO & Managing Member |
| 12:00-12:10 |
AureoGen Biosciences, Inc. |
Ake Elhammer
Chief Executive Officer |
| 12:10-12:20 |
Gentel Biosciences, Inc. |
Alex Vodenlich
President & CEO |
| 12:20-12:30 |
Vestaron Corporation |
John L. McIntyre
President & CEO |
|
| |
| |
TRACK 2 Medical Device Showcase
| Time |
Company |
Presenter |
| 11:00-11:10 |
Compact Particle Acceleration Corp. |
Shawn Guse
President |
| 11:10-11:20 |
Advanced Diamond Technologies, Inc. |
Neil Kane
President |
| 11:20-11:30 |
NeoChord, Inc. |
John Seaberg
Chairman & CEO |
| 11:30-11:40 |
Echometrix |
Barbara Israel
Chief Executive Officer |
| 11:40-11:50 |
Cytopherx, Inc. |
R. James Danehy
Chief Executive Officer |
| 11:50-12:00 |
OrthoData Inc. |
Tim Prell
Chief Executive Officer |
| 12:00-12:10 |
Incept Biosystems |
Christopher Bleck
President & CEO |
| 12:10-12:20 |
Phoenix Nuclear Labs |
Gregory Piefer
President |
| 12:20-12:30 |
Nerites Corporation |
Shaun Lonergan
Chief Executive Officer |
|
| 12:30-2:00 |
Luncheon with Co-Keynote Address
Accelerating Tech Transfer through Inner Disciplinary Research
Dr. Sangtae "Sang" Kim
Executive Director
Morgridge Institute for Research |
Dr. John Wiley
Former Chancellor - UW-Madison
Director - Wisconsin Institutes for Discovery |
| Hosted By: |
 |
|
| 2:00-3:30 |
Presenting Company Showcase |
| |
TRACK 1 Biotechnology & Pharmaceutical Showcase
| Time |
Company |
Presenter |
| 2:00-2:10 |
Akebia Therapeutics, Inc. |
Ian Howes
CFO & VP Corporate Development |
| 2:10-2:20 |
KemPharm, Inc. |
Bob Karr
Chief Executive Officer |
| 2:20-2:30 |
Cellectar, Inc. |
Bill Clarke
President & CEO |
| 2:30-2:40 |
ApoImmune, Inc. |
Steven Downey
President & CEO |
| 2:40-2:50 |
Quintessence Biosciences, Inc. |
Laura Strong
President & COO |
| 2:50-3:00 |
Aarden Pharmaceuticals, Inc. |
Gary Noonan
President & CEO |
| 3:00-3:10 |
Airway Therapeutics, Inc. |
Charles McOsker
Chief Executive Officer |
| 3:10-3:20 |
TheraVasc, LLC |
Tony Giordano
President & CEO |
|
| |
| |
TRACK 2 Medical Device & Healthcare IT Showcase
| Time |
Company |
Presenter |
| 2:00-2:10 |
Novian Health |
Henry “Chip” Appelbaum
President & CEO |
| 2:10-2:20 |
Ratio, Inc. |
Ben Moga
Director |
| 2:20-2:30 |
Axenic Dental |
Mac Waldorf
President & CEO |
| 2:30-2:40 |
Dgimed Ortho, Inc. |
Philip Smith
President & CEO |
| 2:40-2:50 |
iRxReminder LLC |
Anthony Sterns, Ph.D.
Acting Chief Executive Officer |
|
| |
| |
TRACK 2 Diagnostics Showcase
| Time |
Company |
Presenter |
| 2:50-3:00 |
EraGen Biosciences, Inc. |
Irene Hrusovsky
President & CEO |
| 3:00-3:10 |
AssureRx, LLC |
James Burns
President & CEO |
| 3:10-3:20 |
Rapid Diagnostek, Inc.
|
Harry Norris
President & CEO |
|
| 3:20-3:45 |
Networking & Refreshment Break |
| 3:45-4:45 |
Virtual Company Development
This panel will discuss the importance of creating collaborative partnerships to access
specialized resources such as clinical trials management, regulatory affairs and product manufacturing to achieve commercialization goals and marshal scarce resources
Confirmed Moderator:
Peter G Kleinhenz
Venture Partner - Fletcher Spaght Ventures
Managing Director
CID Capital, Inc. |
|
Confirmed Panelists:
Robert Shalwitz
Vice President & CMO
Akebia Therapeutics |
Peter Sausen
Global Vice President, Integrated Drug Development
Covance Laboratories |
Michael E. Jenkins, PhD
General Manager
Catalent Pharma Solutions |
Tracy Warren
General Partner
Battelle Ventures |
|
| 4:45-5:45 |
Corporate Strategic Investing & Acquisitions: What are they looking for?
Business development executives from medical device, diagnostic, pharmaceutical
and biotech companies will discuss:
• What types of technologies and healthcare sectors are they focused on for investments, alliances, or acquisitions?
• At what stage in the company’s development will they evaluate the company for investment or acquisition?
• How would they decide to invest in a venture round versus acquire the company?
Moderators:
Jan Garfinkle
Managing Director
Arboretum Ventures |
Mina Patel Sooch
Managing Partner
Apjohn Ventures / Triathlon Medical Ventures |
Confirmed Panelists:
Kevin Conroy
President & CEO
Exact Sciences Corp |
Christopher J. King
Senior Director, Corporate Development
Medtronic, Inc. |
Michael F. Johnson
Director Corp Business Development
Eli Lilly and Company |
|
|
| |
| 5:45-6:45 |
Cocktail Reception
| Hosted By: |
 |
|
|
| Thursday, November 12th |
| 8:00-9:00 |
Breakfast & Networking Reception |
| 9:00-10:00 |
Coast-to-Coast Healthcare Venture Capital Investing:
Who’s doing what, where, and why?
Some of the most active healthcare VCs from across the country will discuss investment trends and strategies regionally and nationally.
• What kind of deals are they going after and where are they finding them?
• What are the advantages/disadvantages of companies based in the Midwest vs. the East & West Coasts?
• How are Coastal VCs syndicating with Midwest funds?
Moderator:
John Neis
Managing Partner
Venture Investors |
|
Confirmed Panelists:
Rod Altman
Senior Partner
CMEA Ventures |
Ashley Friedman
Senior Associate
Investor Growth Capital, Inc. |
John Fletcher
Founding Partner
Fletcher Spaght, Inc.
|
David Lowe
Partner
Skyline Ventures |
|
| |
| 10:00-10:45 |
The New Regulatory Paths & How BioSimilars are Affecting Reimbursement
Moderators:
Mark DuVal
President
DuVal & Associates |
|
Panelists:
Dan Mans
Vice President, Research and Technology
American Medical Systems |
Carla Monacelli
Managing Partner
Argenta Advisors |
|
| |
| 10:45-11:15 |
Networking & Reception Break |
| 11:15-12:15 |
Presenting Company Showcase
TRACK 1 Biotechnology & Pharmaceutical Showcase
| Time |
Company |
Presenter |
| 11:15-11:25 |
ImmuneWorks, Inc. |
Wade Lange
President & CEO |
| 11:25-11:35 |
BioSystem Development, LLC |
Scott Fulton
Chief Executive Officer |
| 11:35-11:45 |
GWC Technologies Inc. |
Timothy G. Burland
President & CEO |
| 11:45-11:55 |
Metabolic Solutions Development Company |
Robert Beardsley, Ph.D.
Chief Executive Officer |
| 11:55-12:05 |
AllTranz, Inc. |
Clint Dederick
Chief Executive Officer |
| 12:05-12:15 |
Mithridion, Inc. |
Trevor Twose, PhD
Chief Executive Officer |
| 12:15-12:25 |
Phenomenome Discoveries Inc. |
John Hyshka
CFO & COO |
|
| |
| |
TRACK 2 Medical Device Showcase
| Time |
Company |
Presenter |
| 11:15-11:25 |
Flex Biomedical |
Sal Braico
Chief Executive Officer |
| 11:25-11:35 |
Checkpoint Surgical |
|
| 11:35-11:45 |
Siloam Biosciences, Inc. |
Dr. Chong Ahn
President & CEO |
| 11:45-11:55 |
m2m Imaging Corp |
Richard Hullihen
Chief Executive Officer |
| 11:55-12:05 |
CellCura Inc |
Lesley Hutchins
Chief Executive Officer |
| 12:05-12:15 |
Kappametics, Inc. |
Jay Miller
CFO & COO |
| 12:15-12:25 |
NeuWave Medical, Inc |
Laura King
President & CEO |
| 12:25-12:35 |
AxioMed Spine Corporation |
Gerald Baty
Chief Financial Officer |
|
| 12:35-2:00 |
Luncheon & Keynote
The Economy: How High is the Water, Mama?
A review of the current economy and where we are heading including the
important
indicators that will show the water is receding
Joe Morgan, CFA
Chief Investment Officer and Head of Portfolio Management
SVB Asset Management |
|
